Ubs Group Ag Opti Nose, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Opti Nose, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 441 shares of OPTN stock, worth $211. This represents 0.0% of its overall portfolio holdings.

Number of Shares

441

Previous 1,598 72.4%

Holding current value

$211

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.67 - $1.27 $775 - $1,469	-1,157 Reduced 72.4%	441 $0
Q2 2024 Aug 13, 2024	SELL	$0.82 - $1.44 $58,747 - $103,165	-71,643 Reduced 97.82%	1,598 $1,000
Q1 2024 May 13, 2024	SELL	$1.17 - $1.94 $5,706 - $9,461	-4,877 Reduced 6.24%	73,241 $106,000
Q4 2023 Feb 09, 2024	BUY	$1.02 - $1.47 $39,924 - $57,538	39,142 Added 100.43%	78,118 $100,000
Q3 2023 Nov 09, 2023	SELL	$0.93 - $1.38 $6,041 - $8,964	-6,496 Reduced 14.29%	38,976 $47,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.05 $48,152 - $88,931	43,381 Added 2074.65%	45,472 $55,000
Q1 2023 May 12, 2023	SELL	$1.63 - $2.02 $1,633 - $2,024	-1,002 Reduced 32.4%	2,091 $4,000
Q4 2022 Feb 08, 2023	SELL	$1.68 - $3.7 $4,828 - $10,633	-2,874 Reduced 48.16%	3,093 $5,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $4.01 $16,018 - $18,726	4,670 Added 360.06%	5,967 $22,000
Q2 2022 Aug 10, 2022	SELL	$1.76 - $3.82 $11,684 - $25,360	-6,639 Reduced 83.66%	1,297 $5,000
Q1 2022 May 16, 2022	SELL	$1.77 - $2.93 $10,851 - $17,963	-6,131 Reduced 43.58%	7,936 $20,000
Q4 2021 Feb 14, 2022	BUY	$1.55 - $3.1 $21,803 - $43,607	14,067 New	14,067 $22,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $10,835 - $14,570	-4,611 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$2.91 - $3.83 $2,886 - $3,799	-992 Reduced 17.7%	4,611 $14,000
Q1 2021 May 12, 2021	SELL	$3.47 - $4.75 $10,403 - $14,240	-2,998 Reduced 34.86%	5,603 $21,000
Q4 2020 Feb 11, 2021	BUY	$3.2 - $4.98 $27,523 - $42,832	8,601 New	8,601 $36,000
Q3 2020 Nov 12, 2020	SELL	$3.69 - $7.09 $18,461 - $35,471	-5,003 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$3.58 - $7.44 $26,925 - $55,956	-7,521 Reduced 60.05%	5,003 $37,000
Q1 2020 May 01, 2020	SELL	$3.49 - $9.2 $58,841 - $155,112	-16,860 Reduced 57.38%	12,524 $56,000
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $15,524 - $28,251	-2,476 Reduced 7.77%	29,384 $271,000
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $57,650 - $101,708	12,137 Added 61.54%	31,860 $223,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $57,254 - $97,869	8,946 Added 83.01%	19,723 $140,000
Q1 2019 May 14, 2019	BUY	$6.1 - $10.3 $23,790 - $40,170	3,900 Added 56.71%	10,777 $111,000
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $12,176 - $24,853	-2,085 Reduced 23.26%	6,877 $43,000
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $42,945 - $102,820	3,455 Added 62.74%	8,962 $111,000
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $40,425 - $61,359	2,156 Added 64.34%	5,507 $154,000
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $12,775 - $16,718	803 Added 31.51%	3,351 $67,000
Q4 2017 Feb 14, 2018	BUY	$15.2 - $20.76 $38,729 - $52,896	2,548	2,548 $48,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account